Becton Dickinson & Co (NYSE:BDX)
$ 156.36 +3.39 (+2.22%) Market Cap: 43.08 Bil Enterprise Value: 59.55 Bil PE Ratio: 39.58 PB Ratio: 1.79 GF Score: 77/100

Becton Dickinson and Co at Evercore ISI HealthCONx Conference (Virtual) Transcript

Nov 29, 2022 / 01:00PM GMT
Release Date Price: $189.54 (+1.55%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team

Okay. Thanks, everyone, for joining us this morning. It's -- we're officially kicking off HealthCONx 2022 with Becton, Dickinson. It's a pleasure to have BD with us this morning. Look, I mean -- when I think about the macro, the uncertainty, things that have happened, I think it's safe to say that we love steadiness, consistency in numbers. And so I think BD exemplifies that. We have Chris DelOrefice, the CFO; and from the IR team, we have Francesca DeMartino and Adam Reiffe. So with that, Chris, thank you for joining us this morning.

Christopher DelOrefice
Becton, Dickinson and Company - Executive VP & CFO

Yes. Thank you, Vijay. It's my pleasure, and hello to everyone out there. I appreciate you taking the time to join us.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot